- $3.96m
- -$4.26m
Annual cashflow statement for Genprex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.7 | -17.9 | -19.6 | -23.7 | -30.9 |
| Depreciation | |||||
| Non-Cash Items | 3.53 | 4.25 | 4.28 | 4.73 | 5.41 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.193 | -0.261 | 1.01 | 1.36 | 0.698 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -6.92 | -13.9 | -14.3 | -17.6 | -24.7 |
| Capital Expenditures | -0.145 | -0.128 | -0.072 | -0.06 | -0.071 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.802 | -2.21 | -0.011 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.947 | -2.34 | -0.084 | -0.06 | -0.071 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 1.27 | 41.6 | 25.7 | 0.006 | 10.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.6 | 25.3 | 11.3 | -17.7 | -14.2 |